Is Health Catalyst, Inc. (HCAT) a Buy, Sell, or Hold?
NASDAQ : HCAT
Health Catalyst, Inc. — Analyst Ratings
$2.055 USD
-$0.04 (-2.14%)
- Volume
- 128.83K
- Average Volume
- 1.55M
- Market Capitalization
- $151.85M
- P/E Ratio
- -0.55
- Dividend Yield
- 0.00%
- Price Target
- $2.38
- Year High
- $4.12
- Year Low
- $0.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.69
Analyst Consensus Summary
Consensus Rating
Sell
22 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-13.5%
vs Current Price
Price Target
$2.38
Average TargetPrice Target Range
Lowest Target
$1.75
17.4% UPSIDE
Average Target
$2.38
Median Estimate
Highest Target
$3.00
-31.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 22
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 12 | 10 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wells Fargo | Stan Berenshteyn | $1.75 | $1.77 | 2026-06-26 06:01 AM | -1.1% |
| Raymond James | Sarah James | $3 | $1.79 | 2026-03-13 07:24 AM | 67.6% |
| Canaccord Genuity | Richard Close | $2 | $1.79 | 2026-03-13 07:14 AM | 11.7% |
| Canaccord Genuity | Richard Close | $5 | $3.65 | 2025-08-29 06:38 AM | 37.0% |
| KeyBanc | Scott Schoenhaus | $5 | $3.75 | 2025-04-16 07:02 AM | 33.3% |